Role of Bone Marrow Mesenchymal Stem Cells in the Treatment of CCL4 Induced Liver Fibrosis in Albino Rats: A Histological and Immunohistochemical Study.
10.15283/ijsc.2014.7.2.87
- Author:
Soheir Kamal AHMED
1
;
Somaya A MOHAMMED
;
Gehan KHALAF
;
Heba FIKRY
Author Information
1. Department of Histology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. dr_gehankhalaf@hotmail.com
- Publication Type:Original Article
- Keywords:
Bone Marrow;
Liver;
Fibrosis;
CCL4;
Histopathology;
MSCs
- MeSH:
Animals;
Autoimmune Diseases;
Bone Marrow*;
Carbon;
Characidae;
Congenital Abnormalities;
Female;
Fibrosis;
Hand;
Hepatitis;
Humans;
Liver;
Liver Cirrhosis*;
Liver Diseases;
Liver Transplantation;
Male;
Mesenchymal Stromal Cells*;
Metabolic Diseases;
Models, Theoretical;
Rats*;
Substance-Related Disorders
- From:International Journal of Stem Cells
2014;7(2):87-97
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND OBJECTIVES: Variety of pathological factors including viral hepatitis, alcohol and drug abuse, metabolic diseases, autoimmune diseases and congenital abnormalities can cause hepatic injury. Liver transplantation is the treatment of choice for end-stage liver diseases, however, it faces several difficulties. So the aim of the work is to evaluate the effect of bone marrow derived mesenchymal stem cells (BM-MSCs) on the liver structure in carbon tetra chloride CCL4 induced liver fibrosis in rats. MATERIALS AND RESULTS: BM-MSCs were isolated and characterized from long bones of twenty male albino rats. Sixty female rats were divided into the following two groups: Group I; thirty rats which were the control group. Group II; thirty rats were injected intra-peritoneal (IP) by CCL4 twice weekly for four weeks and was further subdivided into the following three subgroups: Subgroup IIA (CCL4 alone); included ten rats which were sacrificed after this four weeks. Subgroup IIB (CCL4/MSCs); included ten rats which were IP injected by a single dose of BM-MSCs and were sacrificed after four weeks. Subgroup IIC (CCL4/recovery); included ten rats which were left for another four weeks without any intervention. Histological examination of liver specimens showed that CCl4 caused variable pathological changes with elevated liver enzymes. Injection of BM-MSCs revealed an improvement in the histological picture of the liver and its enzymatic profile. On the other hand, most of the pathological lesion were still detected in rats of recovery group. CONCLUSIONS: BM-MSC could restore the liver structure and function in experimental model of liver fibrosis.
